COCP
Cocrystal Pharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.86M
P/E Ratio
—
EPS
$-0.72
Beta
1.50
52W High
$2.19
52W Low
$0.86
50-Day MA
$1.28
200-Day MA
$1.18
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Cocrystal Pharma Inc
Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.
Fundamentals
| Revenue (TTM) | 225,000 |
| Gross Profit (TTM) | $-4.84M |
| EBITDA | $-8.97M |
| Operating Margin | -1047.00% |
| Return on Equity | -154.60% |
| Return on Assets | -62.40% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $0.46 |
| Price-to-Book | 3.89 |
| Price-to-Sales (TTM) | 70.47 |
| EV/Revenue | 56.59 |
| EV/EBITDA | 0.66 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 26.90% |
| Shares Outstanding | $13.79M |
| Float | $9.12M |
| % Insiders | 25.44% |
| % Institutions | 5.63% |
Historical Volatility
HV 10-Day
56.63%
HV 20-Day
56.47%
HV 30-Day
71.30%
HV 60-Day
103.54%
HV Rank
68.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.00 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026